Simplex Trading, LLC Aeterna Zentaris Inc. Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$0.17 - $0.37 $5,490 - $11,949	32,297 Added 7067.18%	32,754 $6,000
Q1 2022 May 02, 2022	SELL	$0.33 - $0.42 $23,540 - $29,960	-71,334 Reduced 99.36%	457 $0
Q3 2021 Oct 28, 2021	BUY	$0.59 - $0.88 $177 - $264	300 Added 0.42%	71,791 $62,000
Q2 2021 Aug 12, 2021	BUY	$0.83 - $1.14 $18,039 - $24,776	21,734 Added 43.68%	71,491 $62,000
Q1 2021 Apr 26, 2021	BUY	$0.51 - $3.34 $25,325 - $165,854	49,657 Added 49657.0%	49,757 $56,000
Q4 2020 Feb 02, 2021	BUY	$0.3 - $0.44 $30 - $44	100 New	100 $0
Q2 2019 Jul 26, 2019	SELL	$2.04 - $5.43 $9,838 - $26,188	-4,823 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$3.03 - $4.65 $13,077 - $20,069	4,316 Added 851.28%	4,823 $0
Q4 2018 Jan 16, 2019	BUY	$1.3 - $3.87 $659 - $1,962	507 New	507 $1,000
Q2 2018 Jul 30, 2018	SELL	$1.19 - $2.62 $328 - $723	-276 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$1.46 - $2.41 $10,309 - $17,017	-7,061 Reduced 96.24%	276 $0
Q4 2017 Jan 10, 2018	SELL	$1.87 - $2.7 $15,304 - $22,096	-8,184 Reduced 52.73%	7,337 $17,000
Q3 2017 Oct 25, 2017	BUY	$1.81 - $2.23 $28,093 - $34,611	15,521	15,521 $31,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.